Reduced response-inhibition in obsessive-compulsive disorder measured with topographic evoked potential mapping. (Q48171411)

9 February 2018

title

Reduced response-inhibition in obsessive-compulsive disorder measured with topographic evoked potential mapping. (English)

1 reference

9 February 2018

obsessive-compulsive disorder

main subject

1 reference

1

1 reference

9 February 2018

author name string

Christian Jacob

series ordinal

2

1 reference

9 February 2018

Stefan Unterecker

series ordinal

3

1 reference

9 February 2018

Andreas J Fallgatter

series ordinal

4

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 October 2003

1 reference

9 February 2018

published in

Psychiatry Research

1 reference

9 February 2018

volume

120

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

265-271

1 reference

9 February 2018

fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Functional MRI and the study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Abnormal visual event-related potentials in obsessive-compulsive disorder without panic disorder or depression comorbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

ERP components in Go/Nogo tasks and their relation to inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Long-term reliability of electrophysiologic response control parameters.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Test-retest reliability of electrophysiological parameters related to cognitive motor control.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Stability of late event-related potentials: topographical descriptors of motor control compared with the P300 amplitude

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Electrophysiological signs of reduced prefrontal response control in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Discrepant target detection and action monitoring in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

The time course of brain activations during response inhibition: evidence from event-related potentials in a go/no go task

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Reference-free identification of components of checkerboard-evoked multichannel potential fields

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Abnormal pattern of cortical activation associated with voluntary movement in obsessive-compulsive disorder: an EEG study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Topographic evoked potential mapping in obsessive-compulsive disorder: evidence of frontal lobe dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Obsessive-compulsive disorder: a clinical, neuropsychological and positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Functional anatomy of obsessive-compulsive phenomena

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Improvement predictors in obsessive-compulsive disorder. An event-related potential study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Psychophysiological and clinical value of event-related potentials in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Cognitive deficits in obsessive-compulsive disorder on tests of frontal-striatal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Oculomotor response inhibition abnormalities in pediatric obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Cognitive frontal lobe dysfunction in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

Endogenous event-related potentials in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900188-4

7 January 2021

10.1016/S0165-1781(03)00188-4

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

14561438

1 reference

9 February 2018